Showing results (441-450 of 452) with videos related to
Sort By:
Pageof 46
Cancer Cell|February 10, 2016
Targeting p38 or MK2 Enhances the Anti-Leukemic Activity of Smac-MimeticsNajoua Lalaoui, Kay Hänggi, Gabriela Brumatti, et al.Cell|May 13, 2014
RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesisJames A Rickard, Joanne A O'Donnell, Joseph M Evans, et al.Nature|October 16, 2024
Spatial proteomics identifies JAKi as treatment for a lethal skin diseaseThierry M Nordmann, Holly Anderton, Akito Hasegawa, et al.Nature Communications|September 28, 2023
A common human MLKL polymorphism confers resistance to negative regulation by phosphorylationSarah E Garnish, Katherine R Martin, Maria Kauppi, et al.Nature|October 28, 2016
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer modelsAndrás Kotschy, Zoltán Szlavik, James Murray, et al.EMBO Molecular Medicine|May 15, 2024
An immunohistochemical atlas of necroptotic pathway expressionShene Chiou, Aysha H Al-Ani, Yi Pan, et al.Nature|August 3, 2018
Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growthJonathan B Baell, David J Leaver, Stefan J Hermans, et al.Nature Immunology|April 12, 2024
Biallelic human SHARPIN loss of function induces autoinflammation and immunodeficiencyHirotsugu Oda, Kalpana Manthiram, Pallavi Pimpale Chavan, et al.Nature|December 13, 2019
Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory diseaseNajoua Lalaoui, Steven E Boyden, Hirotsugu Oda, et al.Nature Communications|June 21, 2020
A missense mutation in the MLKL brace region promotes lethal neonatal inflammation and hematopoietic dysfunctionJoanne M Hildebrand, Maria Kauppi, Ian J Majewski, et al.Pageof 46